ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed

Women diagnosed with estrogen-receptor (ER)-positive breast cancer who took tamoxifen for 10 years as adjuvant therapy had lower risk of late recurrence and lower risk of death compared to those who took the drug for 5 years. These results corroborate the findings of the international ATLAS trial.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news